Verastem Inc

Financials

Cash from operating activities -33.51 M-53.5 M-63.67 M-86.46 M-104.77 M-137.51 M -137.51 M Cash from investing activities -47.36 M87 K66.19 M-44.45 M59.97 M-9.62 M — Cash from financing activities 69.63 M6.88 M51.78 M134.19 M54.78 M263.31 M 263.31 M Free cash flow -33.54 M-53.7 M-63.67 M-86.46 M-104.8 M-147.13 M -137.51 M

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

VSTM

Financials

Verastem Inc

Haberler

The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying

H.C. Wainwright, Verastem hissesi için tavsiyesini korudu

3 Best Stocks to Buy Today, 4/11/2026, According to Top Analysts - TipRanks.com

Verastem hissesi, dayanıklı deneme verileriyle BTIG’de Al tavsiyesi aldı

Verastem’in kanser ilacı kombinasyonu 2 yıllık veride dayanıklılık gösterdi

Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market

Verastem: Maintaining "Buy" As 1st Half 2026 Catalysts In Play (NASDAQ:VSTM)

BTIG, Verastem hissesi için Al önerisiyle kapsama başladı

Verastem stock initiated at Buy by BTIG with $19 price target

Wall Street Analysts See a 159.31% Upside in Verastem (VSTM): Can the Stock Really Move This High?

Jefferies, lansman ilerlemesi sonrası Verastem hisse notunu korudu

Jefferies reiterates Verastem stock rating on launch progress